Having the conversation: Individualizing RSV vaccination in older patients.

IF 3.4 4区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cleveland Clinic Journal of Medicine Pub Date : 2024-09-04 DOI:10.3949/ccjm.91.s1.05

Ronan Factora

引用次数: 0

Abstract

The new vaccines against respiratory syncytial virus (RSV) reduce the risk of RSV illness, which is common in older people and carries the risk of hospitalization with its attendant risks such as delirium and physical decline leading to loss of function and independence. Individualized discussions regarding vaccination should weigh the risks of vaccination, which are minor, against the preventive benefits. Discussions incorporating these elements may lead to greater vaccine uptake, especially by those at high risk.

查看原文本刊更多论文

对话：为老年患者个性化接种 RSV 疫苗。

呼吸道合胞病毒 (RSV) 的新型疫苗降低了 RSV 疾病的风险，这种疾病在老年人中很常见，有住院的风险，以及随之而来的风险，如谵妄和身体机能下降，导致功能和独立性丧失。关于疫苗接种的个性化讨论应权衡疫苗接种的轻微风险和预防益处。包含这些因素的讨论可能会提高疫苗接种率，尤其是高风险人群。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cleveland Clinic Journal of Medicine 医学-医学：内科

CiteScore

3.80

自引率

0.00%

发文量

109

审稿时长

6-12 weeks

期刊介绍： The mission of Cleveland Clinic Journal of Medicine (CCJM) is to provide its readers with up-to-date, practical, clinical information relevant to internal medicine, cardiology, and related fields. Consistent with this mission, CCJM focuses on timely review articles and other content that has a continuing-education orientation rather than on original research or case reports. CCJM authors, drawn from Cleveland Clinic and other top medical institutions throughout the world, are asked to identify new findings that are changing the practice of medicine and to advise readers how to apply them in daily patient care. Authors are chosen for their experience, acquired through caring for patients, teaching other physicians, and researching clinical questions.